Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer

Details 詳細情報について

• CRID

  1363107370877771648

• DOI

  10.1016/j.ejca.2012.07.014

• ISSN

  09598049

• Web Site

  https://api.elsevier.com/content/article/PII:S0959804912005758?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0959804912005758?httpAccept=text/plain

• Data Source

  • Crossref